Aytu Biopharma (AYTU) Other Working Capital Changes (2011 - 2026)
Aytu Biopharma (AYTU) reported Other Working Capital Changes of $6492.0 for Q1 2026, up 124.71% year-over-year from $2889.0 in Q1 2025, and up 34.74% quarter-over-quarter from $4818.0 in Q4 2025.
Aytu Biopharma (AYTU) Other Working Capital Changes (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 16 years of Other Working Capital Changes data on file, last reported at $6492.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $6492.0, up 124.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $6492.0 (up 124.71% YoY), and the FY2025 annual result was $5078.0, up 63.12% from the prior year.
- Other Working Capital Changes advanced to $6492.0 in Q1 2026 per AYTU's latest filing, from $4818.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.5 million in Q2 2024 and troughed at -$484000.0 in Q3 2025.
- A 5-year average of $419789.6 and a median of $702.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes soared 23457.88% in 2022, then plunged 297158.82% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $100.0 in 2022, then soared by 515.0% to $615.0 in 2023, then slumped by 33433.33% to -$205000.0 in 2024, then soared by 102.35% to $4818.0 in 2025, then soared by 34.74% to $6492.0 in 2026.
- Business Quant data shows AYTU's Other Working Capital Changes at $6492.0 in Q1 2026, $4818.0 in Q4 2025, and -$484000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,492.00 |
| Mar 31, 2026 | 6,492.00 |
| Dec 31, 2025 | 4,818.00 |
| Dec 31, 2025 | 4,818.00 |
| Sep 30, 2025 | -484,000.00 |
| Sep 30, 2025 | -484,000.00 |
| Jun 30, 2025 | 806,000.00 |
| Jun 30, 2025 | 806,000.00 |
| Mar 31, 2025 | 2,889.00 |
| Mar 31, 2025 | 2,889.00 |
| Dec 31, 2024 | -205,000.00 |
| Dec 31, 2024 | -205,000.00 |
| Sep 30, 2024 | -101,000.00 |
| Sep 30, 2024 | -101,000.00 |
| Jun 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 3.52 Mn |
| Mar 31, 2024 | 702.00 |
| Mar 31, 2024 | 702.00 |
| Dec 31, 2023 | 615.00 |
| Dec 31, 2023 | 615.00 |